Victor Terentiev

Title: Victor Terentiev: Innovator in Kinase Inhibitors

Introduction

Victor Terentiev is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Victor Terentiev holds a patent for a DDR1 inhibitor compound. This compound can have a structure of Formula A, as well as derivatives, prodrugs, salts, stereoisomers, tautomers, polymorphs, or solvates. The patent emphasizes the potential for various chirality at any chiral center, highlighting the versatility and applicability of his invention in therapeutic contexts. He has 1 patent to his name.

Career Highlights

Victor is currently associated with Insilico Medicine IP Limited, where he continues to push the boundaries of innovation in drug development. His work focuses on creating effective treatments that can significantly impact patient care and disease management.

Collaborations

Victor has collaborated with notable professionals in his field, including Aleksandr M Aliper and Yan A Ivanenkov. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Victor Terentiev's contributions to the field of kinase inhibitors exemplify his commitment to innovation and excellence in medicinal chemistry. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.